Literature DB >> 18364154

[Chemotherapy to patients with metastatic carcinoma of the esophagus and gastro-esophageal junction. A survey of a Cochrane review].

Lene Weber Vestermark1, Peter Sørensen, Per Pfeiffer.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18364154

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN： 0041-5782


× No keyword cloud information.
  3 in total

1.  A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.

Authors:  Yi-Fu He; Chu-Shu Ji; Bing Hu; Ping-Sheng Fan; Chang-Lu Hu; Feng-Shou Jiang; Jian Chen; Lei Zhu; Yi-Wei Yao; Wei Wang
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

2.  Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.

Authors:  Ying Liu; Zhonghai Ren; Long Yuan; Shuning Xu; Zhihua Yao; Lei Qiao; Ke Li
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

3.  Study of single nucleotide polymorphisms of FBW7 and its substrate genes revealed a predictive factor for paclitaxel plus cisplatin chemotherapy in Chinese patients with advanced esophageal squamous cell carcinoma.

Authors:  Ying Liu; Shu Ning Xu; Yong Shun Chen; Xiao Yuan Wu; Lei Qiao; Ke Li; Long Yuan
Journal:  Oncotarget       Date:  2016-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.